Proton-coupled oligopeptide transporter family SLC15: Physiological, pharmacological and pathological implications

Molecular Aspects of Medicine

Volumn 34, Issue 2-3, 2013, Pages 323-336

  Smith, David E ^a   Clémençon, Benjamin ^b   Hediger, Matthias A ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Mimetic; Peptide; Peptide transporters; SLC15

Indexed keywords

AMINOLEVULINIC ACID; AMOXICILLIN; CARNOSINE; CEFADROXIL; GLYCYLSARCOSINE; INSULIN; OLIGOPEPTIDE; PEPTIDE TRANSPORTER 1; PEPTIDE TRANSPORTER 2; PROTEIN SLC15A3; PROTEIN SLC15A4; UNCLASSIFIED DRUG; VALACICLOVIR;

DNA POLYMORPHISM; DRUG ABSORPTION; DRUG MEGADOSE; ENTERITIS; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHARMACOGENOMICS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SLC15A1 GENE; SLC15A2 GENE; ULCERATIVE COLITIS;

AMINO ACID SEQUENCE; ANIMALS; GENETIC VARIATION; HUMANS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PHARMACOGENETICS; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPS; SEQUENCE ALIGNMENT; SYMPORTERS;

EID: 84873329542     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2012.11.003     Document Type: Review

References (122)

1. S.A. Adibi Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease Am. J. Physiol. Gastrointest. Liver Physiol. 285 5 2003 G779 G788
2. S. Amasheh, U. Wenzel, M. Boll, D. Dorn, W. Weber, W. Clauss, and H. Daniel Transport of charged dipeptides by the intestinal H+/peptide symporter PepT1 expressed in Xenopus laevis oocytes J. Membr. Biol. 155 3 1997 247 256
3. P. Anderle, C.U. Nielsen, J. Pinsonneault, P.L. Krog, B. Brodin, and W. Sadee Genetic variants of the human dipeptide transporter PEPT1 J. Pharmacol. Exp. Ther. 316 2 2006 636 646
4. P. Balimane, and P. Sinko Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells Biopharm. Drug Dispos. 21 5 2000 165 174
5. U.V. Berger, and M.A. Hediger Distribution of peptide transporter PEPT2 mRNA in the rat nervous system Anat. Embryol. (Berl.) 199 5 1999 439 449
6. F. Berlioz, B. Lepere-Prevot, S. Julien, A. Tsocas, C. Carbon, C. Roze, and R. Farinotti Chronic nifedipine dosing enhances cephalexin bioavailability and intestinal absorption in conscious rats Drug Metab. Dispos. 28 11 2000 1267 1269
7. R.K. Bhardwaj, D. Herrera-Ruiz, N. Eltoukhy, M. Saad, and G.T. Knipp The functional evaluation of human peptide/histidine transporter 1 (hPHT1) in transiently transfected COS-7 cells Eur. J. Pharm. Sci. 27 5 2006 533 542
8. A.B. Bikhazi, M.M. Skoury, D.S. Zwainy, A.R. Jurjus, S.I. Kreydiyyeh, D.E. Smith, K. Audette, and D. Jacques Effect of diabetes mellitus and insulin on the regulation of the PepT 1 symporter in rat jejunum Mol. Pharm. 1 4 2004 300 308
9. C. Boehmer, M. Palmada, F. Klaus, S. Jeyaraj, R. Lindner, J. Laufer, H. Daniel, and F. Lang The peptide transporter PEPT2 is targeted by the protein kinase SGK1 and the scaffold protein NHERF2 Cell Physiol. Biochem. 22 5-6 2008 705 714
10. M.B. Bolger, I.S. Haworth, A.K. Yeung, D. Ann, H. von Grafenstein, S. Hamm-Alvarez, C.T. Okamoto, K.J. Kim, S.K. Basu, S. Wu, and V.H. Lee Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1 J. Pharm. Sci. 87 11 1998 1286 1291
11. M. Boll, D. Markovich, W.-M. Weber, H. Korte, H. Daniel, and H. Murer Expression cloning of a cDNA from rabbit small intestine related to proton-coupled transport of peptides, β-lactam antibiotics and ACE-inhibitors Pflügers Arch.-Eur. J. Physiol. 429 1 1994 146 149
12. M. Brandsch, I. Knutter, and E. Bosse-Doenecke Pharmaceutical and pharmacological importance of peptide transporters J. Pharm. Pharmacol. 60 5 2008 543 585
13. H.Q. Chen, J. Yang, M. Zhang, Y.K. Zhou, T.Y. Shen, Z.X. Chu, X.M. Hang, Y.Q. Jiang, and H.L. Qin Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice Am. J. Physiol. Gastrointest. Liver Physiol. 299 6 2010 G1287 G1297
14. X.Z. Chen, A. Steel, and M.A. Hediger Functional roles of histidine and tyrosine residues in the H(+)-peptide transporter PepT1 Biochem. Biophys. Res. Commun. 272 3 2000 726 730
15. X.Z. Chen, T. Zhu, D.E. Smith, and M.A. Hediger Stoichiometry and kinetics of the high-affinity H+-coupled peptide transporter PepT2 J. Biol. Chem. 274 5 1999 2773 2779
16. K.M. Covitz, G.L. Amidon, and W. Sadee Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions Biochemistry 37 43 1998 15214 15221
17. G. Dalmasso, H.T. Nguyen, S.A. Ingersoll, S. Ayyadurai, H. Laroui, M.A. Charania, Y. Yan, S.V. Sitaraman, and D. Merlin The PepT1-NOD2 signaling pathway aggravates induced colitis in mice Gastroenterology 141 4 2011 1334 1345
18. H. Daniel Molecular and integrative physiology of intestinal peptide transport Annu. Rev. Physiol. 66 2004 361 384
19. H. Daniel, and G. Kottra The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology Pflugers Arch. 447 5 2004 610 618
20. F. Doring, D. Dorn, U. Bachfischer, S. Amasheh, M. Herget, and H. Daniel Functional analysis of a chimeric mammalian peptide transporter derived from the intestinal and renal isoforms J. Physiol. 497 Pt. 3 1996 773 779
21. F. Doring, C. Martini, J. Walter, and H. Daniel Importance of a small N-terminal region in mammalian peptide transporters for substrate affinity and function J. Membr. Biol. 186 2 2002 55 62
22. F. Doring, R. Schmitt, W.M. Bernhardt, M. Klapper, S. Bachmann, H. Daniel, and D.A. Groneberg Hypothyroidism induces expression of the peptide transporter PEPT2 Biol. Chem. 386 8 2005 785 790
23. Y.J. Fei, Y. Kanai, S. Nussberger, V. Ganapathy, F.H. Leibach, M.F. Romero, S.K. Singh, W.F. Boron, and M.A. Hediger Expression cloning of a mammalian proton-coupled oligopeptide transporter Nature 368 6471 1994 563 566
24. Y.J. Fei, J.C. Liu, T. Fujita, R. Liang, V. Ganapathy, and F.H. Leibach Identification of a potential substrate binding domain in the mammalian peptide transporters PEPT1 and PEPT2 using PEPT1-PEPT2 and PEPT2-PEPT1 chimeras Biochem. Biophys. Res. Commun. 246 1 1998 39 44
25. Y.J. Fei, W. Liu, P.D. Prasad, R. Kekuda, T.G. Oblak, V. Ganapathy, and F.H. Leibach Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2 Biochemistry 36 2 1997 452 460
26. D.W. Foley, J. Rajamanickam, P.D. Bailey, and D. Meredith Bioavailability through PepT1: the role of computer modelling in intelligent drug design Curr. Comput. Aided Drug Des. 6 1 2010 68 78
27. I.M. Frey, I. Rubio-Aliaga, A. Siewert, D. Sailer, A. Drobyshev, J. Beckers, M.H. de Angelis, J. Aubert, A. Bar Hen, O. Fiehn, H.M. Eichinger, and H. Daniel Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice Physiol. Genomics 28 3 2007 301 310
28. Ganapathy, V.; Gupta, N.; Martindale, R.G.; 2006. Protein digestion and absorption. In: Johnson, L. (Ed.), Physiology of the Gastrointestinal Tract, fourth ed. Elsevier, Amsterdam, pp. 1667-1692.
29. V. Ganapathy, and F.H. Leibach Is intestinal peptide transport energized by a proton gradient? Am. J. Physiol. 249 2 Pt. 1 1985 G153 G160
30. V. Ganapathy, and F.H. Leibach Carrier-mediated reabsorption of small peptides in renal proximal tubule Am. J. Physiol. 251 6 Pt. 2 1986 F945 F953
31. D.A. Groneberg, F. Doring, P.R. Eynott, A. Fischer, and H. Daniel Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1 Am. J. Physiol. Gastrointest. Liver Physiol. 281 3 2001 G697 G704
32. M.A. Hediger, M.F. Romero, J.B. Peng, A. Rolfs, H. Takanaga, and E.A. Bruford The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction Pflugers Arch. 447 5 2004 465 468
33. D. Herrera-Ruiz, Q. Wang, O.S. Gudmundsson, T.J. Cook, R.L. Smith, T.N. Faria, and G.T. Knipp Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 in vitro cell culture model, and multiple human tissues AAPS PharmSci. 3 1 2001 E9
34. Y. Hu, H. Shen, R.F. Keep, and D.E. Smith Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity J. Neurochem. 103 5 2007 2058 2065
35. Y. Hu, D.E. Smith, K. Ma, D. Jappar, W. Thomas, and K.M. Hillgren Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine Mol. Pharm. 5 6 2008 1122 1130
36. S.A. Ingersoll, S. Ayyadurai, M.A. Charania, H. Laroui, Y. Yan, and D. Merlin The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease Am. J. Physiol. Gastrointest. Liver Physiol. 302 5 2012 G484 G492
37. +-coupled peptide transport via human PEPT1 J. Physiol. 565 Pt 2 2005 429 439
38. D. Jappar, Y. Hu, and D.E. Smith Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice Drug Metab. Dispos. 39 12 2011 2250 2257
39. D. Jappar, S.P. Wu, Y. Hu, and D.E. Smith Significance and regional dependency of peptide transporter (PEPT) 1 in the intestinal permeability of glycylsarcosine: in situ single-pass perfusion studies in wild-type and Pept1 knockout mice Drug Metab. Dispos. 38 10 2010 1740 1746
40. H. Jiang, Y. Hu, R.F. Keep, and D.E. Smith Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice J. Neurochem. 109 5 2009 1536 1543
41. M.A. Kamal, H. Jiang, Y. Hu, R.F. Keep, and D.E. Smith Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null mice Am. J. Physiol. Regul. Integr. Comp. Physiol. 296 4 2009 R986 R991
42. M.A. Kamal, R.F. Keep, and D.E. Smith Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity Drug Metab. Pharmacokinet. 23 4 2008 236 242
43. Y. Kato, K. Yoshida, C. Watanabe, Y. Sai, and A. Tsuji Screening of the interaction between xenobiotic transporters and PDZ proteins Pharm. Res. 21 10 2004 1886 1894
44. G. Kottra, A. Stamfort, and H. Daniel PEPT1 as a paradigm for membrane carriers that mediate electrogenic bidirectional transport of anionic, cationic, and neutral substrates J. Biol. Chem. 277 36 2002 32683 32691
45. A.A. Kulkarni, I.S. Haworth, and V.H. Lee Transmembrane segment 5 of the dipeptide transporter hPepT1 forms a part of the substrate translocation pathway Biochem. Biophys. Res. Commun. 306 1 2003 177 185
46. A.A. Kulkarni, I.S. Haworth, T. Uchiyama, and V.H. Lee Analysis of transmembrane segment 7 of the dipeptide transporter hPepT1 by cysteine-scanning mutagenesis J. Biol. Chem. 278 51 2003 51833 51840
47. J. Lee, I. Tattoli, K.A. Wojtal, S.R. Vavricka, D.J. Philpott, and S.E. Girardin PH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling J. Biol. Chem. 284 35 2009 23818 23829
48. V.H. Lee, C. Chu, E.D. Mahlin, S.K. Basu, D.K. Ann, M.B. Bolger, I.S. Haworth, A.K. Yeung, S.K. Wu, S. Hamm-Alvarez, and C.T. Okamoto Biopharmaceutics of transmucosal peptide and protein drug administration: role of transport mechanisms with a focus on the involvement of PepT1 J. Control Release 62 1-2 1999 129 140
49. H. Lennernäs Animal data: the contributions of the Using chamber and perfusion systems to predicting human oral delivery in vivo Adv. Drug Deliv. Rev. 59 2007 1103 1120
50. N. Lister, P.D. Bailey, I.D. Collier, C.A. Boyd, and J.R. Bronk The influence of luminal pH on transport of neutral and charged dipeptides by rat small intestine, in vitro Biochim. Biophys. Acta 1324 2 1997 245 250
51. R. Liu, A.M. Tang, Y.L. Tan, L.M. Limenta, and E.J. Lee Interethnic differences of PEPT2 (SLC15A2) polymorphism distribution and associations with cephalexin pharmacokinetics in healthy Asian subjects Eur. J. Clin. Pharmacol. 65 1 2009 65 70
52. K. Ma, Y. Hu, and D.E. Smith Peptide transporter 1 is responsible for intestinal uptake of the dipeptide glycylsarcosine: studies in everted jejunal rings from wild-type and Pept1 null mice J. Pharm. Sci. 100 2 2011 767 774
53. K. Ma, Y. Hu, and D.E. Smith Influence of fed-fasted state on intestinal PEPT1 expression and in vivo pharmacokinetics of glycylsarcosine in wild-type and Pept1 knockout mice Pharm. Res. 29 2 2012 535 545
54. B. Mackenzie, Y.J. Fei, V. Ganapathy, and F.H. Leibach The human intestinal H+/oligopeptide cotransporter hPEPT1 transports differently-charged dipeptides with identical electrogenic properties Biochim. Biophys. Acta 1284 2 1996 125 128
55. D. Merlin, M. Si-Tahar, S.V. Sitaraman, K. Eastburn, I. Williams, X. Liu, M.A. Hediger, and J.L. Madara Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules Gastroenterology 120 7 2001 1666 1679
56. D. Merlin, A. Steel, A.T. Gewirtz, M. Si-Tahar, M.A. Hediger, and J.L. Madara HPepT1-mediated epithelial transport of bacteria-derived chemotactic peptides enhances neutrophil-epithelial interactions J. Clin. Invest. 102 11 1998 2011 2018
57. N. Nakamura, S. Masuda, K. Takahashi, H. Saito, M. Okuda, and K. Inui Decreased expression of glucose and peptide transporters in rat remnant kidney Drug Metab. Pharmacokinet. 19 1 2004 41 47
58. A.M. Nassl, I. Rubio-Aliaga, H. Fenselau, M.K. Marth, G. Kottra, and H. Daniel Amino acid absorption and homeostasis in mice lacking the intestinal peptide transporter PEPT1 Am. J. Physiol. Gastrointest. Liver Physiol. 301 1 2011 G128 G137
59. A.M. Nassl, I. Rubio-Aliaga, M. Sailer, and H. Daniel The intestinal peptide transporter PEPT1 is involved in food intake regulation in mice fed a high-protein diet PLoS One 6 10 2011 e26407
60. S. Newstead, D. Drew, A.D. Cameron, V.L. Postis, X. Xia, P.W. Fowler, J.C. Ingram, E.P. Carpenter, M.S. Sansom, M.J. McPherson, S.A. Baldwin, and S. Iwata Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2 EMBO J. 30 2 2011 417 426
61. H.T. Nguyen, G. Dalmasso, K.R. Powell, Y. Yan, S. Bhatt, D. Kalman, S.V. Sitaraman, and D. Merlin Pathogenic bacteria induce colonic PepT1 expression: an implication in host defense response Gastroenterology 137 4 2009 1435 1447
62. R. Noshiro, N. Anzai, T. Sakata, H. Miyazaki, T. Terada, H.J. Shin, X. He, D. Miura, K. Inui, Y. Kanai, and H. Endou The PDZ domain protein PDZK1 interacts with human peptide transporter PEPT2 and enhances its transport activity Kidney Int. 70 2 2006 275 282
63. S.M. Ocheltree, H. Shen, Y. Hu, R.F. Keep, and D.E. Smith Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice J. Pharmacol. Exp. Ther. 315 1 2005 240 247
64. X. Pan, T. Terada, M. Irie, H. Saito, and K. Inui Diurnal rhythm of H+-peptide cotransporter in rat small intestine Am. J. Physiol. Gastrointest. Liver Physiol. 283 1 2002 G57 G64
65. X. Pan, T. Terada, M. Okuda, and K. Inui Altered diurnal rhythm of intestinal peptide transporter by fasting and its effects on the pharmacokinetics of ceftibuten J. Pharmacol. Exp. Ther. 307 2 2003 626 632
66. X. Pan, T. Terada, M. Okuda, and K. Inui The diurnal rhythm of the intestinal transporters SGLT1 and PEPT1 is regulated by the feeding conditions in rats J. Nutr. 134 9 2004 2211 2215
67. M. Pieri, C. Gan, P. Bailey, and D. Meredith The transmembrane tyrosines Y56, Y91 and Y167 play important roles in determining the affinity and transport rate of the rabbit proton-coupled peptide transporter PepT1 Int. J. Biochem. Cell Biol. 41 11 2009 2204 2213
68. J. Pinsonneault, C.U. Nielsen, and W. Sadee Genetic variants of the human H+/dipeptide transporter PEPT2: analysis of haplotype functions J. Pharmacol. Exp. Ther. 311 3 2004 1088 1096
69. Posada, M.M.; Smith, D.E.; 2011a. Importance of PEPT1 in the in vivo absorption and disposition of cefadroxil in wild-type and PepT1 knockout mice. AAPS J.; 13 (S2).
70. Posada, M.M.; Smith, D.E.; 2011b. Relevance of PEPT1 in the intestinal permeability of cefadroxil. AAPS Workshop on Drug Transporters in ADME: From the Bench to the Beside, Bethesda, MD (unpublished results).
71. Z.B. Redzic, J.E. Preston, J.A. Duncan, A. Chodobski, and J. Szmydynger-Chodobska The choroid plexus-cerebrospinal fluid system: from development to aging Curr. Top Dev. Biol. 71 2005 1 52
72. R. Rexhepaj, A. Rotte, D.S. Kempe, M. Sopjani, M. Foller, E.M. Gehring, M. Bhandaru, I. Gruner, A.F. Mack, I. Rubio-Aliaga, A.M. Nassl, H. Daniel, D. Kuhl, and F. Lang Stimulation of electrogenic intestinal dipeptide transport by the glucocorticoid dexamethasone Pflugers Arch. 459 1 2009 191 202
73. R. Rexhepaj, A. Rotte, V. Pasham, S. Gu, D.S. Kempe, and F. Lang PI3 kinase and PDK1 in the regulation of the electrogenic intestinal dipeptide transport Cell Physiol. Biochem. 25 6 2010 715 722
74. I. Rubio-Aliaga, and H. Daniel Peptide transporters and their roles in physiological processes and drug disposition Xenobiotica 38 7-8 2008 1022 1042
75. I. Rubio-Aliaga, I. Frey, M. Boll, D.A. Groneberg, H.M. Eichinger, R. Balling, and H. Daniel Targeted disruption of the peptide transporter Pept2 gene in mice defines its physiological role in the kidney Mol. Cell Biol. 23 9 2003 3247 3252
76. A. Ruhl, S. Hoppe, I. Frey, H. Daniel, and M. Schemann Functional expression of the peptide transporter PEPT2 in the mammalian enteric nervous system J. Comp. Neurol. 490 1 2005 1 11
77. H. Saito, H. Motohashi, M. Mukai, and K. Inui Cloning and characterization of a pH-sensing regulatory factor that modulates transport activity of the human H+/peptide cotransporter, PEPT1 Biochem. Biophys. Res. Commun. 237 3 1997 577 582
78. H. Saito, T. Terada, J. Shimakura, T. Katsura, and K. Inui Regulatory mechanism governing the diurnal rhythm of intestinal H+/peptide cotransporter 1 (PEPT1) Am. J. Physiol. Gastrointest. Liver Physiol. 295 2 2008 G395 G402
79. K. Sakata, T. Yamashita, M. Maeda, Y. Moriyama, S. Shimada, and M. Tohyama Cloning of a lymphatic peptide/histidine transporter Biochem. J. 356 Pt. 1 2001 53 60
80. S. Sasawatari, T. Okamura, E. Kasumi, K. Tanaka-Furuyama, R. Yanobu-Takanashi, S. Shirasawa, N. Kato, and N. Toyama-Sorimachi The solute carrier family 15A4 regulates TLR9 and NOD1 functions in the innate immune system and promotes colitis in mice Gastroenterology 140 5 2011 1513 1525
81. H. Shen, S.M. Ocheltree, Y. Hu, R.F. Keep, and D.E. Smith Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice Drug Metab. Dispos. 35 7 2007 1209 1216
82. H. Shen, D.E. Smith, R.F. Keep, and F.C. Brosius III Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain Mol. Pharm. 1 4 2004 248 256
83. H. Shen, D.E. Smith, R.F. Keep, J. Xiang, and F.C. Brosius III Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus J. Biol. Chem. 278 7 2003 4786 4791
84. H. Shen, D.E. Smith, T. Yang, Y.G. Huang, J.B. Schnermann, and F.C. Brosius III Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney Am. J. Physiol. 276 5 Pt. 2 1999 F658 F665
85. C. Shu, H. Shen, U. Hopfer, and D.E. Smith Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures Drug Metab. Dispos. 29 10 2001 1307 1315
86. C. Shu, H. Shen, N.S. Teuscher, P.J. Lorenzi, R.F. Keep, and D.E. Smith Role of PEPT2 in peptide/mimetic trafficking at the blood-cerebrospinal fluid barrier: studies in rat choroid plexus epithelial cells in primary culture J. Pharmacol. Exp. Ther. 301 3 2002 820 829
87. D.E. Smith, Y. Hu, H. Shen, T.N. Nagaraja, J.D. Fenstermacher, and R.F. Keep Distribution of glycylsarcosine and cefadroxil among cerebrospinal fluid, choroid plexus, and brain parenchyma after intracerebroventricular injection is markedly different between wild-type and Pept2 null mice J. Cereb. Blood Flow Metab. 31 1 2011 250 261
88. D.E. Smith, C.E. Johanson, and R.F. Keep Peptide and peptide analog transport systems at the blood-CSF barrier Adv. Drug Deliv. Rev. 56 12 2004 1765 1791
89. D.E. Smith, A. Pavlova, U.V. Berger, M.A. Hediger, T. Yang, Y.G. Huang, and J.B. Schnermann Tubular localization and tissue distribution of peptide transporters in rat kidney Pharm. Res. 15 8 1998 1244 1249
90. C. Sobin, M. Gutierrez, and H. Alterio Polymorphisms of delta-aminolevulinic acid dehydratase (ALAD) and peptide transporter 2 (PEPT2) genes in children with low-level lead exposure Neurotoxicology 30 6 2009 881 887
91. A. Steel, S. Nussberger, M.F. Romero, W.F. Boron, C.A. Boyd, and M.A. Hediger Stoichiometry and pH dependence of the rabbit proton-dependent oligopeptide transporter PepT1 J. Physiol. 498 Pt. 3 1997 563 569
92. T. Sugiura, Y. Kato, Y. Kubo, and A. Tsuji Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2 Drug Metab. Pharmacokinet. 21 5 2006 375 383
93. T. Sugiura, Y. Kato, T. Wakayama, D.L. Silver, Y. Kubo, S. Iseki, and A. Tsuji PDZK1 regulates two intestinal solute carriers (Slc15a1 and Slc22a5) in mice Drug Metab. Dispos. 36 6 2008 1181 1188
94. K. Takahashi, S. Masuda, N. Nakamura, H. Saito, T. Futami, T. Doi, and K. Inui Upregulation of H(+)-peptide cotransporter PEPT2 in rat remnant kidney Am. J. Physiol. Renal. Physiol. 281 6 2001 F1109 F1116
95. C.S. Temple, J.R. Bronk, P.D. Bailey, and C.A. Boyd Substrate-charge dependence of stoichiometry shows membrane potential is the driving force for proton-peptide cotransport in rat renal cortex Pflugers Arch. 430 5 1995 825 829
96. T. Terada, and K. Inui Peptide transporters: structure, function, regulation and application for drug delivery Curr. Drug Metab. 5 1 2004 85 94
97. T. Terada, and K. Inui Gene expression and regulation of drug transporters in the intestine and kidney Biochem. Pharmacol. 73 3 2007 440 449
98. T. Terada, M. Irie, M. Okuda, and K. Inui Genetic variant Arg57His in human H+/peptide cotransporter 2 causes a complete loss of transport function Biochem. Biophys. Res. Commun. 316 2 2004 416 420
99. T. Terada, H. Saito, M. Mukai, and K.I. Inui Identification of the histidine residues involved in substrate recognition by a rat H+/peptide cotransporter, PEPT1 FEBS Lett. 394 2 1996 196 200
100. T. Terada, H. Saito, K. Sawada, Y. Hashimoto, and K. Inui N-terminal halves of rat H+/peptide transporters are responsible for their substrate recognition Pharm. Res. 17 1 2000 15 20
101. M. Thamotharan, S.Z. Bawani, X. Zhou, and S.A. Adibi Hormonal regulation of oligopeptide transporter pept-1 in a human intestinal cell line Am. J. Physiol. 276 4 Pt. 1 1999 C821 C826
102. A. Tsuji, E. Nakashima, Y. Deguchi, K. Nishide, T. Shimizu, S. Horiuchi, K. Ishikawa, and T. Yamana Degradation kinetics and mechanism of aminocephalosporins in aqueous solution: cefadroxil J. Pharm. Sci. 70 10 1981 1120 1128
103. T. Uchiyama, A.A. Kulkarni, D.L. Davies, and V.H. Lee Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1 Pharm. Res. 20 12 2003 1911 1916
104. A. Urtti, S.J. Johns, and W. Sadée Genomic structure of proton-coupled oligopeptide transporter hPEPT1 and pH-sensing regulatory splice variant AAPS PharmSci. 3 1 2001 E6
105. S.R. Vavricka, M.W. Musch, J.E. Chang, Y. Nakagawa, K. Phanvijhitsiri, T.S. Waypa, D. Merlin, O. Schneewind, and E.B. Chang HPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells Gastroenterology 127 5 2004 1401 1409
106. D. Walker, D.T. Thwaites, N.L. Simmons, H.J. Gilbert, and B.H. Hirst Substrate upregulation of the human small intestinal peptide transporter, hPepT1 J. Physiol. 507 Pt. 3 1998 697 706
107. M. Wang, X. Zhang, H. Zhao, Q. Wang, and Y. Pan Comparative analysis of vertebrate PEPT1 and PEPT2 genes Genetica 138 6 2010 587 599
108. U. Wenzel, I. Gebert, H. Weintraut, W.M. Weber, W. Clauss, and H. Daniel Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells J. Pharmacol. Exp. Ther. 277 2 1996 831 839
109. U. Wenzel, S. Kuntz, S. Diestel, and H. Daniel PEPT1-mediated cefixime uptake into human intestinal epithelial cells is increased by Ca2+ channel blockers Antimicrob. Agents Chemother. 46 5 2002 1375 1380
110. J.F. Westphal, F. Jehl, J.M. Brogard, and C. Carbon Amoxicillin intestinal absorption reduction by amiloride: possible role of the Na(+) -H+ exchanger Clin. Pharmacol. Ther. 57 3 1995 257 264
111. J.F. Westphal, J.H. Trouvin, A. Deslandes, and C. Carbon Nifedipine enhances amoxicillin absorption kinetics and bioavailability in humans J. Pharmacol. Exp. Ther. 255 1 1990 312 317
112. K.A. Wojtal, J.J. Eloranta, P. Hruz, H. Gutmann, J. Drewe, A. Staumann, C. Beglinger, M. Fried, G.A. Kullak-Ublick, and S.R. Vavricka Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients Drug Metab. Dispos. 37 9 2009 1871 1877
113. Wu, S.-P.; Jappar, D.; Hu, Y.; Smith, D.E.; 2009. Regional intestinal permeability of glycylsarcosine in wild-type and PepT1 null mice as determined by in situ single-pass intestinal perfusion. AAPS J.; 11(S2).
114. R.J. Xavier, and D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 7152 2007 427 434
115. Xie, Y.; Smith, D.E.; 2012. Regional permeability of 5-aminolevulinic acid in wild-type and PepT1 null mice as determined by in situ single-pass intestinal perfusions. AAPS J.; 14(S2).
116. T. Yamashita, S. Shimada, W. Guo, K. Sato, E. Kohmura, T. Hayakawa, T. Takagi, and M. Tohyama Cloning and functional expression of a brain peptide/histidine transporter J. Biol. Chem. 272 15 1997 10205 10211
117. Yang, B.; Amidon, G.L.; Smith, D.E.; 2011. Contribution of PEPT1 to the pharmacokinetics of antiviral drug acyclovir after oral administration of its prodrug valacyclovir in wild-type and Pept1 null mice. AAPS J.; 13(S2).
118. Yang, B.; Smith, D.E.; 2010. PEPT1-mediated permeability of the antiviral prodrug valacyclovir in intestinal segments of wild-type and Pept1 null mice. AAPS J.; 12(S2).
119. A.K. Yeung, S.K. Basu, S.K. Wu, C. Chu, C.T. Okamoto, S.F. Hamm-Alvarez, H. von Grafenstein, W.C. Shen, K.J. Kim, M.B. Bolger, I.S. Haworth, D.K. Ann, and V.H. Lee Molecular identification of a role for tyrosine 167 in the function of the human intestinal proton-coupled dipeptide transporter (hPepT1) Biochem. Biophys. Res. Commun. 250 1 1998 103 107
120. Z.M. Zair, J.J. Eloranta, B. Stieger, and G.A. Kullak-Ublick Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney Pharmacogenomics 9 5 2008 597 624
121. E.Y. Zhang, D.J. Fu, Y.A. Pak, T. Stewart, N. Mukhopadhyay, S.A. Wrighton, and K.M. Hillgren Genetic polymorphisms in human proton-dependent dipeptide transporter PEPT1: implications for the functional role of Pro586 J. Pharmacol. Exp. Ther. 310 2 2004 437 445
122. M. Zucchelli, L. Torkvist, F. Bresso, J. Halfvarson, A. Hellquist, F. Anedda, G. Assadi, G.B. Lindgren, M. Svanfeldt, M. Janson, C.L. Noble, S. Pettersson, M. Lappalainen, P. Paavola-Sakki, L. Halme, M. Farkkila, U. Turunen, J. Satsangi, K. Kontula, R. Lofberg, J. Kere, and M. D'Amato PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease Inflamm. Bowel Dis. 15 10 2009 1562 1569